Neuwave
Device
Ethicon Endo-Surgery Inc.
Total Payments
$5.9M
Transactions
1,861
Doctors
644
Companies
6
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $940,460 | 540 | 205 |
| 2023 | $1.9M | 513 | 222 |
| 2022 | $2.1M | 390 | 150 |
| 2021 | $943,144 | 418 | 202 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.7M | 655 | 96.6% |
| Food and Beverage | $71,517 | 1,092 | 1.2% |
| Consulting Fee | $36,523 | 13 | 0.6% |
| Royalty or License | $35,120 | 2 | 0.6% |
| Travel and Lodging | $33,628 | 90 | 0.6% |
| Space rental or facility fees (teaching hospital only) | $25,000 | 9 | 0.4% |
Payments by Type
Research
$5.7M
655 transactions
General
$201,787
1,206 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NW-2021-05: Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) Phase II Prospective Trial for Microwave Ablation as a Local Cure Society of Interventional Oncology/Dr. Constantinos Sofocleous | Ethicon Endo-Surgery Inc. | $2.5M | 0 |
| A Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue Lesions | Ethicon Endo-Surgery Inc. | $1.5M | 0 |
| A Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue Lesions | Ethicon Inc. | $523,114 | 0 |
| A Propsective Multicenter Study of Transbronchial Microwave Ablation Using Robotic-Assisted Bronchoscopy in Patients with Oligometastatic or Primary Tumors in the Lung | Ethicon Endo-Surgery Inc. | $299,404 | 0 |
| Correlation of Targeted Ablation Defect and Minimal Margin with Local Tumor Progression after Treatment of Liver Malignancies NW201801 | Ethicon Inc. | $120,000 | 0 |
| 4D flow and perfusion MRI for predicting microwave ablation zones in combination embolization-ablation therapy - NW-2020-01 | Ethicon Endo-Surgery Inc. | $72,453 | 0 |
| Correlation of Targeted Ablation Defect and Minimal Margin with Local Tumor Progression after Treatment of Liver Malignancies NW201801 | Ethicon Endo-Surgery Inc. | $68,614 | 0 |
| Development of NEUWAVE Microwave Ablation Algorithm Using Large Animal Model NW-2021-03 Dr. Wayne L. Hofstetter | Ethicon Endo-Surgery Inc. | $66,134 | 0 |
| Ablation of Lung Lesions Using Microwave Energy A Basket Study ALLY NW201701 Dr. Hofstetter | Ethicon Endo-Surgery Inc. | $61,256 | 0 |
| Ablation of Lung Lesions Using Microwave Energy A Basket Study ALLY NW201701 Dr. Hofstetter | Ethicon Inc. | $60,000 | 0 |
| 4D flow and perfusion MRI for predicting microwave ablation zones in combination embolization-ablation therapy - NW-2020-01 Dr. Jason Chiang | Ethicon Endo-Surgery Inc. | $53,571 | 0 |
| NeuWave Registry of Bone Microwave Ablation/NW-2022-04 | Ethicon Endo-Surgery Inc. | $47,500 | 0 |
| Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics in Hepato-Pancreato-Biliary Solid Tumors - NW-2021-01 Investigator: Dr. David Iannitti | Ethicon Endo-Surgery Inc. | $36,777 | 0 |
| Ablation Confirmation 3D Assessments of the Ablation Zone after Microwave Ablation for Colorectal Cancer Pulmonary Metastases / NW-2022-05 | Ethicon Endo-Surgery Inc. | $30,000 | 0 |
| In Vivo Evaluation of Ablation Zones With and Without Prior Intra-Arterial Embolization in an Oncopig Renal Tumor Model - NW-2020-03 Investigator: Dr. Samuel L. Rice | Ethicon Endo-Surgery Inc. | $27,350 | 0 |
| In Vivo Evaluation of Intra-Arterial Embolization Prior to Microwave Ablation in a Large Animal Swine Oncopig Tumor Model NW-2020-03 Investigator: Dr. Samuel L. Rice | Ethicon Endo-Surgery Inc. | $27,350 | 0 |
| NW-2018-05 Pre-clinical feasibility of trans-bronchial MW of normal lung tissue in porcine model | Ethicon Inc. | $25,000 | 0 |
| Pre-clinical feasibility of trans-bronchial MW of normal lung tissue in porcine model NW-2018-05 | Ethicon Inc. | $24,734 | 0 |
| Analysis of Tumor Ablation Margins in non-CRC Hepatic Metastases/NW-2023-01 | Ethicon Endo-Surgery Inc. | $18,630 | 0 |
| NEU_2020_03 | Ethicon Endo-Surgery Inc. | $14,400 | 3 |
Top Doctors Receiving Payments for Neuwave — Page 26
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , FNP | Family | Dallas, TX | $13.46 | 1 |
| , PA-C | Physician Assistant | Dallas, TX | $13.46 | 1 |
| , M.D | Transplant Hepatology | Dallas, TX | $13.46 | 1 |
| , D.O | Gastroenterology | Dallas, TX | $13.46 | 1 |
| , M.D | Surgery | Dallas, TX | $13.46 | 1 |
| , FNP-C | Family | Dallas, TX | $13.46 | 1 |
| , PA-C | Physician Assistant | Dallas, TX | $13.46 | 1 |
| , AGACNP-BC | Critical Care Medicine | Dallas, TX | $13.46 | 1 |
| , PA-C | Physician Assistant | Dallas, TX | $13.46 | 1 |
| , M.D | Transplant Surgery | Dallas, TX | $13.46 | 1 |
| , MD | Vascular & Interventional Radiology | Duarte, CA | $13.33 | 1 |
| , MD | Diagnostic Radiology | Los Angeles, CA | $13.15 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Austin, TX | $12.60 | 1 |
| , MD | Urology | Oakland, CA | $12.48 | 1 |
| , M.D | Diagnostic Radiology | Philadelphia, PA | $12.05 | 1 |
| Michael Dombrowski | Vascular & Interventional Radiology | Chicago, IL | $12.02 | 1 |
| , MD | Neuroradiology | Chicago, IL | $12.01 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Grand Junction, CO | $11.50 | 1 |
| Varun Rachakonda | Diagnostic Radiology | Sugar Land, TX | $11.18 | 1 |
| , M.D | Diagnostic Radiology | Danville, PA | $2.81 | 1 |
Ad
Manufacturing Companies
- Ethicon Endo-Surgery Inc. $4.8M
- Ethicon Inc. $911,946
- Ethicon US, LLC $94,848
- Medical Device Business Services, Inc. $46,240
- Biosense Webster, Inc. $14,000
- Janssen Research & Development, LLC $121.98
Product Information
- Type Device
- Total Payments $5.9M
- Total Doctors 644
- Transactions 1,861
About Neuwave
Neuwave is a device associated with $5.9M in payments to 644 healthcare providers, recorded across 1,861 transactions in the CMS Open Payments database. The primary manufacturer is Ethicon Endo-Surgery Inc..
Payment data is available from 2021 to 2024. In 2024, $940,460 was paid across 540 transactions to 205 doctors.
The most common payment nature for Neuwave is "Unspecified" ($5.7M, 96.6% of total).
Neuwave is associated with 20 research studies, including "NW-2021-05: Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) Phase II Prospective Trial for Microwave Ablation as a Local Cure Society of Interventional Oncology/Dr. Constantinos Sofocleous" ($2.5M).